Capital Advisors Ltd’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4
Closed 1749
2022
Q3
$0 Buy
+4
New ﹤0.01% 1610
2022
Q1
Sell
-1
Closed 1285
2021
Q4
$0 Buy
+1
New ﹤0.01% 972